In March 2025, the company declared new options for the direct-to-shopper featuring of its Wegovy weight loss drug. The company founded a different pharmacy, termed NovoCare, which would demand shoppers $499 each month for access to the drug, below fifty percent the price of the drug by means of other pharmaceutical distribution networks.[fifty thr